PPARA and metabolic dysfunction-associated steatotic liver disease: Clinical and animal studies have confirmed that PPARα, acyl coenzyme A oxidase 1 (ACOX1), and CPT1A are significantly down-regulated in NAFLD liver [62, 64, 65].